<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Russian Journal of Immunology</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">302</article-id><article-id pub-id-type="doi">10.31857/S102872210006697-1</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE ROLE OF NGAL FOR PREDICTING RENAL DAMAGE IN PEDIATRIC PRACTICE</article-title><trans-title-group xml:lang="ru"><trans-title>РОЛЬ NGAL ДЛЯ ПРОГНОЗИРОВАНИЯ ПОВРЕЖДЕНИЯ ПОЧЕК В ПЕДИАТРИЧЕСКОЙ ПРАКТИКЕ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kalmetyeva</surname><given-names>L. R.</given-names></name><name xml:lang="ru"><surname>Кальметьева</surname><given-names>Л. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, allergist-immunologist,</p><p>Ufa</p></bio><bio xml:lang="ru"><p>к. м. н., аллерголог-иммунолог,</p><p>450106, Уфа, ул. Степана Кувыкина 98</p></bio><email>imun-lab@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ibrahimova</surname><given-names>L. G.</given-names></name><name xml:lang="ru"><surname>Ибрагимова</surname><given-names>Л. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>allergist-immunologist,</p><p>Ufa</p></bio><bio xml:lang="ru"><p>аллерголог-иммунолог,</p><p>Уфа</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Prolygina</surname><given-names>D. D.</given-names></name><name xml:lang="ru"><surname>Пролыгина</surname><given-names>Д. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, allergist-immunologist,</p><p>Ufa</p></bio><bio xml:lang="ru"><p>к. м. н., аллерголог-иммунолог,</p><p>Уфа</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Republican Сhildren Сlinical Нospital</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Республиканская детская клиническая больница» Минздрава РБ</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2019-07-15"><day>15</day><month>07</month><year>2019</year></pub-date><pub-date date-type="collection"><year>2019</year></pub-date><volume>22</volume><issue>2-2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>789</fpage><lpage>791</lpage><history><date date-type="received" iso-8601-date="2020-06-04"><day>04</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-06-04"><day>04</day><month>06</month><year>2020</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2020-06-04"><day>04</day><month>06</month><year>2020</year></date></event-desc></event><event event-type="accepted"><event-desc>Accepted:<date date-type="accepted" iso-8601-date="2020-06-04"><day>04</day><month>06</month><year>2020</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2019-07-15"><day>15</day><month>07</month><year>2019</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Kalmetyeva L.R., Ibrahimova L.G., Prolygina D.D.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Кальметьева Л.Р., Ибрагимова Л.Г., Пролыгина Д.Д.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Kalmetyeva L.R., Ibrahimova L.G., Prolygina D.D.</copyright-holder><copyright-holder xml:lang="ru">Кальметьева Л.Р., Ибрагимова Л.Г., Пролыгина Д.Д.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/302">https://rusimmun.ru/jour/article/view/302</self-uri><abstract xml:lang="en"><p>As it is known, serum creatinine and glomerular filtration rate are considered to be markers of kidney damage. In chronic kidney disease, these markers reveal a late stage of kidney damage, when drug therapy is not always effective and the process of kidney damage is irreversible. In recent years, special attention has been paid to the search for predictors of acute and relapses of chronic renal damage, which could lead to the detection of premorbid pathological changes in the kidneys, to determine the nature and differentiate the defeat of various parts of the nephron, to establish the stage of the process, to assess the severity of inflammation and the intensity of fi brogenesis. One of these early markers is NGAL are investigated.</p></abstract><trans-abstract xml:lang="ru"><p>Как известно, маркерами повреждения почек (ПП) принято считать протеинурию, повышенный уровень креатинина сыворотки крови, снижение скорости клубочковой фильтрации, количества выделяемой мочи. При хронической болезни почек данные маркеры выявляют уже в позднюю стадию поражения почек, когда лекарственная терапия не всегда эффективна и процесс поражения почек необратим. В последние годы особое внимание уделяется поиску новых предикторов острого и рецидивов хронического ПП, что способствовало бы выявлению преморбидных патологических изменений в почках, определению степени и характера поражения различных отделов нефрона, оценке выраженности воспаления и интенсивности фиброгенеза. Одним из ранних маркеров ПП является липокалин, ассоциированный с желатиназой нейтрофилов или липокалин-2(NGAL).</p></trans-abstract><kwd-group xml:lang="en"><kwd>NGAL</kwd><kwd>u-NGAL</kwd><kwd>acute renal injury</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>NGAL</kwd><kwd>u-NGAL</kwd><kwd>острое почечное повреждение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Kjeldsen L., Johnsen A.H., Sengeløv H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase // J. Biol. Chem. 1993; 268: 10425–10432. (Типовая, англоязычная).</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., Barasch J., Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury // Clin. J. Am. Soc. Nephrol. 2003; 14: 2534–2543. (Типовая, англоязычная).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Jaya Mishra, Catherine Dent, Ridwan Tarabishi, Mark M Mitsnefes, Qing Ma, Caitlin Kelly, Stacey M Ruff , Kamyar Zahedi, Mingyuan Shao, Judy Bean, Kiyoshi Mori, Jonathan Barasch, Prasad Devarajan. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker for acute renal injury after cardiac surgery // Lancet. 2005; 365: 1231–1238. (Типовая, англоязычная). 4. Mishra J., Mori K., Devarajan P., Kelly C. Kidney NGAL is a novel early marker of acute injury following transplantation // Pediatr. Nephrol. 2006; 21: 856– 863. (Типовая, англоязычная).</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>5. Wagener G., Jan M., Kim M., Mori K., Barasch J. M., Sladen R. N., Lee H. T. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery // Anesthesiology. 2006; 105: 485–491. (Типовая, англоязычная).</mixed-citation></ref></ref-list></back></article>
